ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,255, issued on Dec. 9, was assigned to iTeos Belgium SA (Gosselies, Belgium).
"Anti-TREM2 antibodies and methods of use" was invented by Catherine Hoofd (Gosselies, Belgium), Thibaut Janss (Gosselies, Belgium), Romain Pirson (Gosselies, Belgium), Virginie Rabolli (Gosselies, Belgium), Yvonne McGrath (Gosselies, Belgium), Reece Marillier (Gosselies, Belgium), Quentin Dubray (Gosselies, Belgium), Clotilde Hoyos (Gosselies, Belgium), Julie Chesne (Gosselies, Belgium), Chiara Martinoli (Milan), Stefan Loverix (Ternat, Belgium) and Laura Saerens (Gosselies, Belgium).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are anti-TREM2 antibodies. P...